| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0095 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |